Magnetic resonance imaging diagnosis of carcinoid heart disease.
Carcinoid tumors are associated with the production of a number of bioactive substances that might deposit on the endocardium (endocardial fibroelastosis) and produce cardiac failure. Carcinoid heart disease usually presents as right-sided valvular heart disease. Even if the diagnosis is frequently made by transthoracic echocardiography, cardiac magnetic resonance imaging adds valuable information when evaluating cardiac structures that might be difficult to analyze on echocardiography.
Bastarrika
Gorka
G
Department of Radiology, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain. bastarrika@unav.es
Cao
María González
MG
Cano
David
D
Barba
Joaquín
J
de Buruaga
José D Sáenz
JD
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D002275:Carcinoid Heart Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D002276:Carcinoid Tumor / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D016461:Chemoembolization, Therapeutic / Q000379:methods; D003937:Diagnosis, Differential; D004452:Echocardiography / Q000379:methods; D006801:Humans; D007414:Intestinal Neoplasms / Q000150:complications* / Q000175:diagnosis; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods; D008297:Male; D009206:Myocardium / Q000473:pathology; D015282:Octreotide / Q000627:therapeutic use; D014261:Tricuspid Valve / Q000601:surgery
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide